Champions Oncology Inc. reported its financial results for the first quarter of fiscal 2026, ending July 31, 2025. The company achieved total revenue of $14 million, marking a decrease from the previous year's first quarter, but showing sequential growth that met expectations. The company recorded an adjusted EBITDA of $59,000, down from $2.0 million in the first quarter of fiscal 2025. Champions reported a loss from operations of $527,000 compared to an income from operations of $1.3 million in the same period last year. David Miller, CFO of Champions Oncology, noted that the company anticipates continued topline expansion and margin improvement driven by a healthy services pipeline and growing demand for proprietary data offerings. The company also announced the appointment of Rob Brainin as Chief Executive Officer to lead the next phase of growth.